For its fourth fiscal quarter (ending December 31), DexCom Inc (NASDAQ: DXCM) has reported a -42% decline in E.P.S. from $0.67 a year ago to $0.39 in the current quarter. This performance was $-0.11 short of the consensus estimate of $0.50. For the latest four quarters through December 31, E.P.S. were $1.46 versus $1.40 for the same period a year ago — an increase of 4%.
Recent Price Action
On 2/13/25, DexCom Inc (NASDAQ: DXCM) stock rose slightly by 0.3%, closing at $84.09. Moreover, exceptionally high trading volume at 204% of normal accompanied the advance. Relative to the market the stock has been extremely weak over the last nine months and has declined -5.3% during the last week.
Current PriceTarget Research Rating
DexCom has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. DexCom has a poor Power Rating of 23 and a poor Appreciation Score of 18, leading to the Lowest Value Trend Rating.
Rating Review
In light of this discouraging new earnings information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment